TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Heart disease related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Confirmed objective response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion virological success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Sperm Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change from Baseline in Progressive Sperm Motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change from Baseline in Normal Sperm Morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in psoriatic Body Surface Area compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in target lesion severity compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change of Physician Global Assessment compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic value of at-home PG vs PSG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' Overall Preference for a specific treatment profile
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of COVID-19 breakthrough infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of hospital admission for COVID-19 breakthrough infections
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Rate of death for COVID-19 breakthrough infections patients
Endpoint domain: Mortality/survival
Primary endpoint: Time at which the maximum plasma concentration is observed (tmax) of acetaminophen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the acetaminophen concentration-time curve: AUCinf
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to new-onset or progression of chronic kidney disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: GPE <50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in total motile sperm count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Diagnostic performance of EDACS for acute cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in 2-hour blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline level of pleasure and arousal
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sentence Perception in Noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validity and reliability of Oral Health Impact on Daily Life questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients with obstructive azoospermia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of patients with non obstructive azoospermia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of patients that will respond to endoscopic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of patients that will need sperm extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Impact on relationship to food
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Impact on Perceived Wellness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Indicator of renal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: An early biomarker of kidney injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: The change of inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Patients with Safe Microdevice Procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients with Feasible Microdevice Procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in irritable bowel symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Occurrences of adverse events and complications
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Adverse Events (AEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Reversal rate of prediabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of homeostasis model assessment-insulin resistance (HOMA-IR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of participants with mild, moderate or severe disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients receiving therapeutic intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Margin-negative (R0) resection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: efficacy index of post-exposure prophylaxis against COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Total postoperative analgesic fentanyl dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Recovery (QoR-15) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Applicator Preference
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Total Patients Reached
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Lumbar ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liebowitz Social Anxiety Scale (LSAS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: modified ashworth scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: stroke-specific quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The Functional Independence Measure
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: User experiences of hum connected toothbrush
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent Change in Non-ceruloplasmin-bound Copper in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Lead Migration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of abdominal pain, hematemesis and bloody stools
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of successful procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: AUC in C-peptide stimulation test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Time to Spontaneous Void
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Audiologic assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pancreatitis activity scoring system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: exercise-related cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Emotional eating score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: safety of closure of cystic duct and artery
Endpoint domain: Adverse events/effects
Primary endpoint: efficiency of closure of cystic duct and artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: fine motor skills
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: compliance to the 12-week DAA treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intervention Attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Level of Participation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Number of participants with treatment related AEs meeting DLT-defined criteria
Endpoint domain: Adverse events/effects
Primary endpoint: Appropriate dose of milademetan based on DLT-defined adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment emergent AE of the identified RP2D
Endpoint domain: Adverse events/effects
Primary endpoint: Change in brain connectivity between STS and NAc
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in structured laboratory observations of child-assessor interactions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Absolute Change in Percent Predicted Forced Expiratory Volume in 1 second (ppFEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ability to produce neutrophil extracellular traps (NETs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Diet score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diastasis abdominal consequences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with Therapeutic Home Exercise Program
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change From Baseline in Pruritus Numeric Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS Pain score at Injection Site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fagotti score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood loss estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Amygdala Reactivity during fear processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in skin conductance response to trauma cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary iodine concentration during 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bio-availability of iodine in the intervention/supplement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of willingness to communicate about ACP
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of advanced care wishes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of perceived self-efficacy to communicate
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Types and number of organism(s) causing surgical site infection
Endpoint domain: Adverse events/effects
Primary endpoint: Pulse rate (BPM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPO2 saturation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QoR15 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Volume of myocardium with abnormal perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of myocardium with late gadolinium enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recovery from shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect of stroke early rehabilitation using telemedicine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum brain-derived neurotrophic factor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMI Maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ideal Cardiovascular Health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Screening behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean values of kᵢₒ*V of the entire tumor region
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Perceived mask performance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Chronic Kidney Disease Self-Management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes of 6-Minute Walk Test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of Timed Up and Go Test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of 13-Step Stair Test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of Pick Up Penny from Floor Test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of Short Physical Performance Battery results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Score at 24 Hours Post Medication Abortion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confirmed best overall response rate (BORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of symptoms of PTSD
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of the pain severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of the disability score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Novel Word Learning Task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pseudoword Discrimination Task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Complete clearance of biodegradable stent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of endometrial cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engh and Massin Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum plasma concentration [Cmin] of TKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse drug reactions and treatment outcomes of TKI
Endpoint domain: Adverse events/effects
Primary endpoint: Amount of Blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in NIH Toolbox Emotional Support Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Three-Item Loneliness Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the Majeed pelvic score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Hematologic Improvement-Erythroid (HI-E) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in maximal strength of quadriceps and calf muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in predicted peak vo2 max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inventory of Psychosocial Functioning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinician-Administered PTSD Scale-5 (CAPS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area Under the Concentration-time curve from time zero to Infinity (AUC[0 to infinity]) of Camlipixant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed plasma concentration (Cmax) of Camlipixant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subclinical arthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: severity of maternal function
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Numerical Rating Scale (NRS) score for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the Investigational Product
Endpoint domain: Adverse events/effects
Primary endpoint: Behavior Problems Checklist
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concordance of carotid-femoral pulse wave velocity (PWVcf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Brain metastases free survival
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of Microvascular dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall response rate lasting at least 4 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of intraoperative hemostatic intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Disease-specific activity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield of chest wall fat pad biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nutritional Risk Screening 2002 (NRS 2002)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient-Generated Subjective Global Assessment (PG-SGA)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Wound Bed Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Myosteatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of participation in each arm
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Spasticity: Clinical measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Spasticity: Neurophysiological measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unfavourable outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: intestinal and systemic markers of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 2-hour pain-free
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: peri-implant marginal bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of participants who experienced serious adverse events (SAEs) at 48 hours post targeted biopsy sampling procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who experienced serious adverse events (SAEs) at 30 days post targeted biopsy sampling procedure
Endpoint domain: Adverse events/effects
Primary endpoint: nasogastric tube application skill success levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Visual Analogue Scale (VAS) pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral health impact profile (OHIP)-14 scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline in self-report anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in severity of depression symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Gastric Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Overall Mental Health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: False negative rate of Cone Beam for the diagnosis of otosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complication in 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: Feeding practice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of postpartum women who agree to HPV vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of HPV vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction to receive the HPV vaccine
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 3-year event free survival (EFS)
Endpoint domain: Mortality/survival
Primary endpoint: Motivation for Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing